Clinical trial · Interventional
Propofol and Sevoflurane for Catheter-Related Bladder Discomfort
Effect of Propofol and Sevoflurane on Postoperative Catheter-Related Bladder Discomfort
NCT02252445CI-TRIAL-00023739completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigators want to evaluate the efficacy of the propofol and sevoflurane for the prevention of catheter-related bladder discomfort.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Anesthesia | — | UNRESOLVED | — |
| Catheter Site Discomfort | — | UNRESOLVED | — |
| Complications | — | UNRESOLVED | — |
| Urinary Bladder Neoplasms | Bladder Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Propofol | Drug | — | UNRESOLVED |
| Sevoflurane | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Propofol
- description
- Propofol will be administered as the anesthetic maintenance agent.
- interventionNames
- Drug: Propofol
- type
- EXPERIMENTAL
- label
- Sevoflurane
- description
- Sevoflurane will be administered as the anesthetic maintenance agent.
- interventionNames
- Drug: Sevoflurane
Primary outcomes (1)
- measure
- Catheter-related Bladder Discomfort
- timeFrame
- 1 hour postoperatively
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 19 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Patients scheduled for transurethral bladder excision under general anesthesia * ASA I-III Exclusion Criteria: * Foley catheter less than 18 Fr. * Patients with obstruction of urinary tract * Patients with neurogenic bladder * Patients with severe obesity * Patients with neurologic disorder * Patients with chronic pain * Patients with allergic history to propofol or sevoflurane
References
Publications (0)
Data not yet available
No reference posted for this study.